How I agree with Jim Cosgrove’s moving letter about the perils of classifying children and young people into categories and the desirability of an inclusive approach to all manifestations of the human experience.
However, as the mother of an adult son who was diagnosed with “non-typical Asperger’s” at the age of 20, I can say that the diagnosis was for him a liberation. It was a recognition that his inability to understand or relate to certain ways of doing things was not a sign of stupidity or moral failure but because he had a different way of seeing the world from the norm, which was not his fault.
Oxford Biodynamics PLC (LON:OBD) was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer and other diseases including ALS.
